Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults

Journal of the American Geriatrics Society

Volumn 56, Issue 4, 2008, Pages 652-660

  Kaplan, Robert C ^a   McGinn, Aileen P ^a   Pollak, Michael N ^b   Kuller, Lewis ^c   Strickler, Howard D ^a   Rohan, Thomas E ^a   Xue, XiaoNan ^a   Kritchevsky, Stephen B ^d   Newman, Anne B ^c   Psaty, Bruce M ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Disability; Insulinlike growth factor (IGF); Older adults

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL STATUS; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; WALKING SPEED;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; FOLLOW-UP STUDIES; HAND STRENGTH; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES; WALKING;

EID: 41549163949     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01637.x     Document Type: Article

References (46)

1. Longo VD, Finch CE. Evolutionary medicine: From dwarf model systems to healthy centenarians? Science 2003 299 : 1342 1346.
2. Kimura KD. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans [comment]. Science 2001 292 : 107 110.
3. Flurkey K, Papaconstantinou J, Miller RA et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A 2001 98 : 6736 6741.
4. Franklin SL, Ferry RJ Jr., Cohen P. Rapid insulin-like growth factor (IGF)-independent effects of IGF binding protein-3 on endothelial cell survival. J Clin Endocrinol Metab 2003 88 : 900 907.
5. Rajah R, Lee KW, Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: Role of Bcl-2 phosphorylation. Cell Growth Differ 2002 13 : 163 171.
6. Lewitt MS, Denyer GS, Cooney GJ et al. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991 129 : 2254 2256.
7. Lee PD, Giudice LC, Conover CA et al. Insulin-like growth factor binding protein-1: Recent findings and new directions. Proc Soc Exp Biol Med 1997 216 : 319 357.
8. Kratz G, Lake M, Ljungstrom K et al. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: Selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp Cell Res 1992 202 : 381 385.
9. Clemmons DR, Gardner LI. A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis. J Cell Physiol 1990 145 : 129 135.
10. Gomez-Merino D, Chennaoui M, Drogou C et al. Influence of energy deficiency on the insulin-like growth factor I axis in a military training program. Horm Metab Res 2004 36 : 506 511.
11. Fan J, Char D, Bagby GJ et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 1995 269 : R1204 R1212.
12. Samstein B, Hoimes ML, Fan J et al. IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production. Biochem Biophys Res Commun 1996 228 : 611 615.
13. Axelsson J, Qureshi AR, Divino-Filho JC et al. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? Eur J Clin Nutr 2006 60 : 718 726.
14. Mynarcik DC, Frost RA, Lang CH et al. Insulin-like growth factor system in patients with HIV infection: Effect of exogenous growth hormone administration. J Acquir Immune Defic Syndr 1999 22 : 49 55.
15. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994 15 : 80 101.
16. Lang CH, Vary TC, Frost RA. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 2003 144 : 3922 3933.
17. Liu H, Bravata DM, Olkin I et al. Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007 146 : 104 115.
18. Papadakis MA, Grady D, Black D et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996 124 : 708 716.
19. Blackman MR, Sorkin JD, Munzer T et al. Growth hormone and sex steroid administration in healthy aged women and men: A randomized controlled trial. JAMA 2002 288 : 2282 2292.
20. Colbert LH, Rosen CJ, Goodpaster BH et al. Insulin-like growth factor-1. J Am Geriatr Soc 2004 52 : 1962 1963.
21. Janssen JA, Stolk RP, Pols HA et al. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 Levels in healthy elderly individuals. Relation to self-reported quality of health and disability. Gerontology 1998 44 : 277 280.
22. Cappola AR, Xue QL, Ferrucci L et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003 88 : 2019 2025.
23. van den Beld AW, Blum WF, Pols HA et al. Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. Eur J Endocrinol 2003 148 : 627 634.
24. Roubenoff R, Parise H, Payette HA et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med 2003 115 : 429 435.
25. Saydah S, Graubard B, Ballard-Barbash R et al. Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 2007 166 : 518 526.
26. Laughlin GA, Barrett-Connor E, Criqui MH et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004 89 : 114 120.
27. Harrela M, Qiao Q, Koistinen R et al. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 2002 34 : 144 149.
28. Johnsen SP, Hundborg HH, Sorensen HT et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005 90 : 5937 5941.
29. Vasan RS, Sullivan LM, D'Agostino RB et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study. Ann Intern Med 2003 139 : 642 648.
30. Kaplan RC, McGinn AP, Pollak MN et al. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. J Clin Endocrinol Metab 2007 92 : 1319 1325.
31. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991 1 : 263 276.
32. Cushman M, Cornell ES, Howard PR et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995 41 : 264 270.
33. Ives DG, Fitzpatrick AL, Bild DE et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 1995 5 : 278 285.
34. Rosano C, Kuller LH, Chung H et al. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults. J Am Geriatr Soc 2005 53 : 649 654.
35. Fried LP, Kronmal RA, Newman AB et al. Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 1998 279 : 585 592.
36. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol 1991 134 : 895 907.
37. Payette H, Roubenoff R, Jacques PF et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: The Framingham Heart Study. J Am Geriatr Soc 2003 51 : 1237 1243.
38. Wolk K, Larsson SC, Vessby B et al. Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men. J Clin Endocrinol Metab 2004 89 : 1879 1884.
39. Janssen JA, Stolk RP, Pols HA et al. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: Relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998 18 : 277 282.
40. Harrela M, Koistinen R, Tuomilehto J et al. Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men. Ann Med 2000 32 : 424 428.
41. Rajpathak S, McGinn AP, Strickler HD et al. Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Hormone IGF Res 2007 Sep 26 [Epub ahead of print].
42. Schoen RE, Schragin J, Weissfeld JL et al. Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiol Biomarkers Prev 2002 11 : 581 586.
43. Lewitt MS, Hall K, Bang P et al. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metabolism 2005 54 : 275 280.
44. Kalme T, Seppala M, Qiao Q et al. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 2005 90 : 1550 1556.
45. van den Beld AW, Bots ML, Janssen JA et al. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003 157 : 25 31.
46. Pinheiro SP, Holmes MD, Pollak MN et al. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 2005 14 : 2147 2153.